Clinical Trial Update: 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Emory University is comparing 2-hour versus 6-hour oxaliplatin infusions in patients with gastrointestinal cancers and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Emory University | Conditions: Malignant Digestive System Neoplasm | Phase 2 | Status: RECRUITING